Campaign News
What does the Women’s Health Strategy mean for breast cancer?
Although women in the UK on average live longer than men, they spend more time in poor health. The strategy aims to address this by tackling...
#NoTimeToWaste – Pushing for ambition in breast cancer diagnosis
This month, the Breast Cancer Now team held an event in Parliament to launch our latest campaign, #NoTimeToWaste, which is focused on improv...
Access to breast cancer drugs: mid-year review
We recap which breast cancer drugs have been approved for use on the NHS so far this year and share an update on which breast cancer drugs a...
Shaping the Scottish Cancer Strategy
The Scottish Government is currently developing a new cancer strategy – a 10 year plan to improve cancer outcomes in Scotland. The new strat...
Health and Care Bill: a missed opportunity to address the workforce crisis
The Health and Care Bill received Royal Assent on 28 April 2022, meaning it has now become law. Unfortunately, we don't think it went far en...
It's important for breast cancer patients to share our experiences - both good and bad
Tracey and Elizabeth were both diagnosed with breast cancer during the pandemic and agreed to share their experiences with the Health...
Despite years of campaigning, we still don't know how many people in the UK are living with secondary breast cancer
For 15 years, Breast Cancer Now has been campaigning for better information on those living with secondary breast cancer. We still don't hav...
Shaping the government's 10-year cancer plan
The government is planning to launch a new 10-year cancer plan, which will determine the long term approach to cancer services in England. T...
Time for Trodelvy - Great News
Last July, we launched our Time For Trodelvy campaign to ensure that all eligible patients could access Trodelvy, an exciting new drug that ...
How we've campaigned for breast cancer progress in 2021
As 2021 comes to a close, we wanted to highlight some of the key issues we’ve been campaigning on this year, as well as some big wins we’ve ...
Time for Trodelvy - our progress so far
Earlier this year, we launched a campaign to ensure all eligible patients can access Trodelvy, an exciting new drug that could give some peo...
Securing the future of the breast cancer workforce
In this blog, we will look at the work we are doing alongside a coalition of over 50 health organisations, including Cancer Research, Macmil...
How we're campaigning to improve treatment, care and services for breast cancer patients in Northern Ireland
An update on the ways in which we are committed to improving standards for people living with breast cancer in Northern Ireland.
Breast Cancer Now visits parliament to give evidence on cancer services
Last week, Breast Cancer Now was invited to give evidence to the Health and Social Care Select Committee’s inquiry on cancer services.
NICE gives provisional 'no' to secondary breast cancer treatment tucatinib - so what now?
In October 2021, we were very disappointed to learn that the National Institute for Health and Care Excellence (NICE) was provisionally unab...
Why we need more focus on secondary breast cancer
We’re committed to improving treatment, care and services for people living with secondary breast cancer, which is why it’s a central part o...
Secondary counts – our secondary breast cancer campaign win
Today, we are excited to announce that we have finally secured a long-overdue secondary breast cancer audit in England, delivering on one of...
Helping the NHS understand the experiences of people with secondary breast cancer
The experiences of people living with secondary breast cancer are unique, which is why our secondary breast cancer campaign has been calling...
New drug trastuzumab deruxtecan available on Cancer Drugs Fund
A new targeted drug for treating breast cancer that has spread has been approved by the National Institute for Health and Care Excellence (N...